Crossref journal-article
Springer Science and Business Media LLC
Psychopharmacology (297)
Bibliography

Blackwell, A. D., Paterson, N. S., Barker, R. A., Robbins, T. W., & Sahakian, B. J. (2008). The effects of modafinil on mood and cognition in Huntington’s disease. Psychopharmacology, 199(1), 29–36.

Authors 5
  1. Andrew D. Blackwell (first)
  2. Nicole S. Paterson (additional)
  3. Roger A. Barker (additional)
  4. Trevor W. Robbins (additional)
  5. Barbara J. Sahakian (additional)
References 43 Referenced 35
  1. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381 (10.1146/annurev.ne.09.030186.002041) / Annu Rev Neurosci by GE Alexander (1986)
  2. Anderson KE, Marshall FJ (2005) Behavioral symptoms associated with Huntington’s disease. Adv Neurol 96:197–208 Review / Adv Neurol by KE Anderson (2005)
  3. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003) Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54(12):1465–1468 (10.1016/S0006-3223(03)00609-7) / Biol Psychiatry by AR Aron (2003)
  4. Bechara A, Tranel D, Damasio AR (2002) The somatic marker hypothesis and decision-making. In: Grafman J (ed) Handbook of neuropsychology, vol. 7. 2nd edn. Elsevier Science BV, Amsterdam, pp 117–143 / Handbook of neuropsychology, vol. 7 by A Bechara (2002)
  5. Beck AT, Steer RA (1987) Beck depression inventory manual. Psychological Corporation, San Antonio, TX / Beck depression inventory manual by AT Beck (1987)
  6. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218 (10.1111/j.2044-8341.1974.tb02285.x) / Br J Med Psychol by A Bond (1974)
  7. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98(4):437–451 (10.1016/S0092-8674(00)81973-X) / Cell by RM Chemelli (1999)
  8. Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease. J Nucl Med 47(2):215–222 / J Nucl Med by A Ciarmiello (2006)
  9. Deroche-Gamonet V, Darnaudery M, Bruins-Slot L, Piat F, Le Moal M, Piazza PV (2002) Study of the addictive potential of modafinil in naïve and cocaine-experienced rats. Psychopharmacology 161(4):387–395 (10.1007/s00213-002-1080-8) / Psychopharmacology by V Deroche-Gamonet (2002)
  10. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1987) Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson’s disease: evidence for a specific attentional dysfunction. Neuropsychologia 27(11–12):1329–1343 / Neuropsychologia by JJ Downes (1987)
  11. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131(2):196–206 (10.1007/s002130050284) / Psychopharmacology by R Elliott (1997)
  12. Evenden J (1999) The pharmacology of impulsive behaviour in rats V: the effects of drugs on responding under a discrimination task using unreliable visual stimuli. Psychopharmacology 143(2):111–122 (10.1007/s002130050926) / Psychopharmacology by J Evenden (1999)
  13. Ferraro L, Antonelli T, O’Connor WT, Tanganelli S, Rambert FA, Fuxe K (1997) Modafinil: an antinarcoleptic drug with a different neurochemical profile to damphetamine and dopamine uptake blockers. Biol Psychiatry 42:1181–1183 (10.1016/S0006-3223(97)00353-3) / Biol Psychiatry by L Ferraro (1997)
  14. Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T, NEST-HD Consortium (2003) Profile of cognitive progression in early Huntington’s disease. Neurology 61(12):1702–1706 (10.1212/01.WNL.0000098878.47789.BD) / Neurology by AK Ho (2003)
  15. Huntington Study Group (1996) The unified Huntington’s disease rating scale: reliability and consistency. Mov Disord 11:136–142 (10.1002/mds.870110204) / Mov Disord by Huntington Study Group (1996)
  16. Ishizuka T, Sakamoto Y, Sakurai T, Yamatodani A (2003) Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 339(2):143–146 (10.1016/S0304-3940(03)00006-5) / Neurosci Lett by T Ishizuka (2003)
  17. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998a) Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain 121(Pt 7):1329–1341 (10.1093/brain/121.7.1329) / Brain by AD Lawrence (1998)
  18. Lawrence AD, Weeks RA, Brooks DJ, Andrews TC, Watkins LH, Harding AE, Robbins TW, Sahakian BJ (1998b) The relationship between striatal dopamine receptor binding and cognitive performance in Huntington’s disease. Brain 121(Pt7):1343–1355 (10.1093/brain/121.7.1343) / Brain by AD Lawrence (1998)
  19. Logan GD (1994) On the ability to inhibit thought and action. In: Dagenbach D, Carr TH (eds) Inhibitory processes in attention, memory and language. Academic, San Diego, pp 189–239 / Inhibitory processes in attention, memory and language by GD Logan (1994)
  20. Marin RS (1996) Apathy, concept, syndrome, neural mechanisms and treatment. Clinical Neuropsychiatry 1(4):303–314 / Clinical Neuropsychiatry by RS Marin (1996)
  21. Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the apathy evaluation scale. Psychiatry Res 38(2):143–162 (10.1016/0165-1781(91)90040-V) / Psychiatry Res by RS Marin (1991)
  22. Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW (1999) Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease. Psychopharmacology (Berl) 146:162–174 (10.1007/s002130051102) / Psychopharmacology (Berl) by MA Mehta (1999)
  23. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES (2005) Disintegration of the sleep–wake cycle and circadian timing in Huntington’s disease. J Neurosci 25(1):157–163 (10.1523/JNEUROSCI.3842-04.2005) / J Neurosci by AJ Morton (2005)
  24. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999) Emotional bias and inhibitory control processes in mania and depression. Psychol Med 29:1307–1321 (10.1017/S0033291799001233) / Psychol Med by FC Murphy (1999)
  25. Nelson H (1982) National adult reading test manual. Windsor NFER-Nelson, UK / National adult reading test manual by H Nelson (1982)
  26. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28:1021–1034 (10.1016/0028-3932(90)90137-D) / Neuropsychologia by AM Owen (1990)
  27. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW (1995) Visuo-spatial short term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 33:1–24 (10.1016/0028-3932(94)00098-A) / Neuropsychologia by AM Owen (1995)
  28. Pavese N, Andrews TC, Brooks DH, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P (2003) Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study. Brain 126(pt5):1127–1135 (10.1093/brain/awg119) / Brain by N Pavese (2003)
  29. Petersen A, Gil J, Maat-Schieman ML, Bjorkqvist M, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P, Li JY, Roos RA, Sundler F, Mulder H, Brundin P (2005) Orexin loss in Huntington’s disease. Hum Mol Genet 14(1):39–47 (10.1093/hmg/ddi004) / Hum Mol Genet by A Petersen (2005)
  30. Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH (2006) Diffusion tensor imaging in presymptomatic and early Huntington’s disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 21(9):1317–1325 (10.1002/mds.20979) / Mov Disord by HD Rosas (2006)
  31. Scammel TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB (2000) Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20(22):8620–8628 (10.1523/JNEUROSCI.20-22-08620.2000) / J Neurosci by TE Scammel (2000)
  32. Taylor FB, Russo J (2000) Efficacy of modafinil compared to dextoamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 10(4):311–320 Winter (10.1089/cap.2000.10.311) / J Child Adolesc Psychopharmacol by FB Taylor (2000)
  33. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003a) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165(3):260–269 (10.1007/s00213-002-1250-8) / Psychopharmacology by DC Turner (2003)
  34. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003b) Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology (Berl) 168(4):455–464 (10.1007/s00213-003-1457-3) / Psychopharmacology (Berl) by DC Turner (2003)
  35. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004a) Modafinil improves cognition and response inhibition in adult attention-deficit-hyperactivity disorder. Biol Psychiatry 55(10):1031–1040 (10.1016/j.biopsych.2004.02.008) / Biol Psychiatry by DC Turner (2004)
  36. Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29(7):1363–1373 (10.1038/sj.npp.1300457) / Neuropsychopharmacology by DC Turner (2004)
  37. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063–1070 (10.1037/0022-3514.54.6.1063) / J Pers Soc Psychol by D Watson (1988)
  38. Wechsler D (1981) Wechsler adult intelligence scale—revised. The Psychological Corporation, New York / Wechsler adult intelligence scale—revised by D Wechsler (1981)
  39. Werheid K, Hoppe C, Thöne A, Müller U, Müngersdorf M, Von Cramon DY (2002) The adaptive digit ordering test: clinical application, reliability and validity of a verbal working memory test. Arch Clin Neuropsychol 17:547–565 (10.1093/arclin/17.6.547) / Arch Clin Neuropsychol by K Werheid (2002)
  40. Willie JT, Renthal W, Chemelli RM, Miller MS, Scammell TE, Yanagisawa M, Sinton CM (2005) Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience 130(4):983–995 (10.1016/j.neuroscience.2004.10.005) / Neuroscience by JT Willie (2005)
  41. Wisor JP, Eriksson KS (2005) Dopaminergic–adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132(4):1027–1034 (10.1016/j.neuroscience.2005.02.003) / Neuroscience by JP Wisor (2005)
  42. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM (2001) Dopaninergic role in stimulant-induced wakefulness. J Neurosci 21(5):1787–1794 (10.1523/JNEUROSCI.21-05-01787.2001) / J Neurosci by JP Wisor (2001)
  43. Wong YN, King SP, Laughton WB, McCormick GC, Grebow PE (1998) Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers. J Clin Pharmacol 38:276–282 (10.1002/j.1552-4604.1998.tb04425.x) / J Clin Pharmacol by YN Wong (1998)
Dates
Type When
Created 17 years, 3 months ago (May 31, 2008, 12:10 a.m.)
Deposited 6 years, 3 months ago (May 23, 2019, 4:06 p.m.)
Indexed 1 week, 4 days ago (Aug. 26, 2025, 3:07 a.m.)
Issued 17 years, 3 months ago (June 1, 2008)
Published 17 years, 3 months ago (June 1, 2008)
Published Online 17 years, 3 months ago (June 1, 2008)
Published Print 17 years, 2 months ago (July 1, 2008)
Funders 0

None

@article{Blackwell_2008, title={The effects of modafinil on mood and cognition in Huntington’s disease}, volume={199}, ISSN={1432-2072}, url={http://dx.doi.org/10.1007/s00213-008-1068-0}, DOI={10.1007/s00213-008-1068-0}, number={1}, journal={Psychopharmacology}, publisher={Springer Science and Business Media LLC}, author={Blackwell, Andrew D. and Paterson, Nicole S. and Barker, Roger A. and Robbins, Trevor W. and Sahakian, Barbara J.}, year={2008}, month=jun, pages={29–36} }